Abdelwahed Sayed

Abdelwahed Sayed


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2020 in Synthetic Communications
Verified
Journal Article
Open access
SASukinah H. Ali
Sukinah H. Ali
ASAbdelwahed Sayed
Abdelwahed Sayed
This study covers the literature documents available on the chemistry of preparation of thiazoles. Additionally, we cover the biological activities of certain thiazoles. The information of several artificial paths and varied physico-chemical factors of such thiazols made especial consideration of medicinal chemists to yield combinatorial library and carry out thorough efforts in the search of thiazoles Graphical Abstract

2 February 2015 in Molecules
Verified
Journal Article
Open access
PDF file
MAMohammed Alomair
Mohammed Alomair
ASAbdelwahed Sayed
Abdelwahed Sayed
MYMagdy M. Youssef
Magdy M. Youssef
An expedient synthesis of novel triazoles, tetrazine and thiadiazoles, using conveniently accessible and commercially available starting materials has been achieved. The synthesized compounds were characterized by spectroscopic and elemental analyses, and screened for their antibacterial activities against four different strains, namely E. coli, P. aeruginosa, S. aureus and B. megaterium. In particular, the compounds 5, 24 and 26h exhibited excellent antibacterial activities compared to the reference antibiotic. To get further insight about their behavior, these compounds were tested for their antioxidant activities via SOD-like activity, DPPH free radical scavenging activity, ABST and NO, which showed promising results. Furthermore, these compounds effectively promoted the cleavage of genomic DNA as well, in the absence of any external additives.

24 September 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
LAlaila Al-Mutabagani
laila Al-Mutabagani
FAFathy Abdelrazek
Fathy Abdelrazek
Sobhi M. GomhaSobhi M. Gomha
Sobhi M. Gomha
AHAli Hebishy
Ali Hebishy
MAMohamed Abdelfattah
Mohamed Abdelfattah
MEMahmoud M. Elaasser
Mahmoud M. Elaasser
The reaction of 2-(1-(2-(2-(4-methoxybenzylidene)hydrazinyl)-4-methylthiazol-5-yl)ethylidene)hydrazinecarbothioamide with a range of hydrazonoyl chlorides and α-halo-compounds yielded three new series of thiazole derivatives. Chemical and physical techniques were used to analyze all newly prepared derivatives (1H-NMR, 13C-NMR, FT-IR and mass spectrometry). The potential antimicrobial and anticancer properties of the synthesized derivatives were investigated using various in vitro biological experiments. Most of the thiazole compounds tested were effective against Gram-positive and Gram-negative bacteria. In addition, a minimum inhibition concentration was determined for the antibiotic properties of the most active produced substances. The cytotoxic activities were tested on HepG-2 (liver carcinoma), HCT-116 (colorectal carcinoma) and MDA-MB-231 (breast carcinoma) cell lines in comparison with cisplatin reference drug and using colorimetric MTT assay. The results detected that compound 10c was the most potent against the three tested cell lines. Interestingly, when the tested compounds were evaluated for their toxicity against normal (MRC-5) cells, they exhibited low toxic effects indicating the safe use of most of them that may require further in vivo and pharmacological studies.

1 August 2010 in Tetrahedron Letters
Verified
Journal Article
Closed access
ASAbdelwahed Sayed
Abdelwahed Sayed

13 March 2015 in Macromolecules
Verified
Journal Article
Closed access
JTJianwei Tu
Jianwei Tu
STSamuel J. Tucker
Samuel J. Tucker
SCStephen Christensen
Stephen Christensen
ASAbdelwahed Sayed
Abdelwahed Sayed
WJWilliam L. Jarrett
William L. Jarrett
JWJeffrey S. Wiggins
Jeffrey S. Wiggins